YORW - High Doses Of Dividend Growth Expected From Pfizer Eli Lilly Bristol Myers In December
- Dividend boosts in the latter half of November were as expected, but with some surprises.
- Among the upside surprises were Royal Gold and Aflac, who both came in with large double-digit increases.
- The theme for December is drug manufacturers and healthcare, as this month brings increases from 16 more companies, including Pfizer, Eli Lilly and Bristol Myers.
- Other companies expected to announce double-digit boosts in December include Mastercard, Graco, Stryker, Balchem, and Toro Company.
For further details see:
High Doses Of Dividend Growth Expected From Pfizer, Eli Lilly, Bristol Myers In December